BioCentury
ARTICLE | Company News

Pfizer to increase list price of 41 drugs

November 16, 2018 10:54 PM UTC

Pfizer Inc. (NYSE:PFE) said it plans to increase the list price for 41 medicines, effective Jan. 15. Last month, Chairman and CEO Ian Read said the pharma will likely end its agreement to defer drug price increases and return to "business as normal" by year end (see "Pfizer Likely to Remove Lid on Drug Price Increases in January").

Pfizer said 37 drugs will see price increases of 5%, while three products will increase by 3% and one by 9%. The 41 medicines account for 10% of the company's portfolio, and Pfizer said it plans to maintain current list prices for the other 90%...

BCIQ Company Profiles

Pfizer Inc.